Compare NBIX & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | SCI |
|---|---|---|
| Founded | 1992 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.3B |
| IPO Year | 1996 | 1994 |
| Metric | NBIX | SCI |
|---|---|---|
| Price | $172.01 | $79.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 4 |
| Target Price | ★ $180.91 | $98.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | ★ 41.95 | 7.65 |
| EPS | ★ 1.91 | 0.97 |
| Revenue | $161,626,000.00 | ★ $4,309,234,000.00 |
| Revenue This Year | $24.73 | $4.03 |
| Revenue Next Year | $13.14 | $3.73 |
| P/E Ratio | $89.54 | ★ $80.28 |
| Revenue Growth | ★ 977.51 | 2.93 |
| 52 Week Low | $122.14 | $68.41 |
| 52 Week High | $181.18 | $88.67 |
| Indicator | NBIX | SCI |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 60.85 |
| Support Level | $153.96 | $79.11 |
| Resistance Level | N/A | $84.13 |
| Average True Range (ATR) | 4.57 | 1.69 |
| MACD | -0.61 | 0.40 |
| Stochastic Oscillator | 49.24 | 97.68 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.